MUDr. Eva Hošková
Specialization: Endocrinology and diabetology
Clinics: AFI – Prague 6
Language skills: Czech English
Curriculum Vitae
Education
- 2009–2015: Charles University, Third Faculty of Medicine – General Medicine
- 2014: Internship – Clinic of Gynecology and Obstetrics, Maribor
- 2014: Internship – Clinic of Traumatology and Surgery, Maribor
- Since 2016: PhD Programme, First Faculty of Medicine, Charles University – Human Physiology and Pathophysiology
Board Certification
- 2023: Specialized Qualification in Endocrinology and Diabetology
Professional Experience
- 2015–present: Diabetologist–Endocrinologist, Diabetes Centre IKEM, Prague
Certifications
- Brookwood Certificate in Essential GCP
- TOEFL iBT Certificate
Research and Publications
-
Hyperbaric oxygen therapy in tinnitus with normal hearing in association with combined treatment (Holý R., Praženica P., Stoláriková E., et al.).
-
Stoláriková, E. & Hahn, A. (2014). Postural findings on Tetrax Balance Assessment in patients with Ménière’s disease. Presented at Neurooto 2014.
-
Stoláriková, E. et al. (2015). Comparison of complications in patients undergoing total thyroidectomy with and without neuromonitoring. Student Research Conference, Third Faculty of Medicine, 2015.
-
Stoláriková, E. et al. (2016). Effect of metformin on cardiac function and metabolic parameters in patients with type 2 diabetes/prediabetes and chronic heart failure. 52nd Diabetes Days, 2016.
-
Metabolic Inflexibility in Patients with Type 2 Diabetes and Heart Failure. Lecture at ADA 79th Scientific Sessions, San Francisco, 2019.
-
Presented virtually at ADA 80th Scientific Sessions, Chicago, 2020 and the Virtual EASD Annual Meeting 2020.
-
A plant-based meal reduces postprandial oxidative and dicarbonyl stress… Nutrition & Metabolism (London). 2021;18(1):84.
-
Dysregulation of epicardial adipose tissue in cachexia due to heart failure… Journal of Cachexia, Sarcopenia and Muscle. 2020;11(6):1614–1627.
Other Professional Activities
Participation in clinical trials (Novo Nordisk, AstraZeneca, DiagNode)